CX Institutional’s Bruker BRKR Stock Holding History

CX Institutional’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-80	Closed	-$4K	–	807
2019 Q2	$4K	Buy	+80	New	+$3.37K	﹤0.01%	638

Other funds holding BRKR

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

CX Institutional's BRKR Position: Q3 2019 in Review

CX Institutional sold out of Bruker (BRKR) in Q3 2019, closing a stake of 80 shares — an estimated $4K sold.

CX Institutional first reported a position in BRKR in Q2 2019 and held it in 1 quarter. The position peaked at $4K in Q2 2019. 249 funds tracked by Wall St. Rank hold BRKR as of Q3 2019.

CX Institutional reported no remaining Bruker position as of Q3 2019 after selling out during the quarter.
CX Institutional sold 80 Bruker shares in Q3 2019, an estimated $4K.
CX Institutional first reported a position in Bruker in Q2 2019 and held it in 1 quarter.
CX Institutional's Bruker position peaked at $4K in Q2 2019.
249 funds tracked by Wall St. Rank held Bruker as of Q3 2019.

Based on CX Institutional's 13F filing for Q3 2019, filed 10 Oct 2019.